Skip to main content

Table 4 Laboratory diagnostic findings during the course of infection in blood

From: Comparison of clinical and immunological findings in gnotobiotic piglets infected with Escherichia coli O104:H4 outbreak strain and EHEC O157:H7

  

Negative

E. coli O104:H4

E. coli O157:H7

Median (min–max); number of animal examined

Median (min–max); number of animal examined

Median (min–max); number of animal examined

Time range: reference range

T1

T2

T3

T1

T2

T3

T1

T2

T3

Red blood count

 Haematocrit L/l

0.21–0.37

0.29 (0.24–0.34); 3

0.24 (0.19–0.27); 3

(0.24–0.29); 2

0.25 (0.19–0.35); 6

0.23 (0.21–0.29); 6

0.26 (0.18–0.33); 5

0.22 (0.14–0.31); 4

0.26 (0.23–0.33); 3

0.3; 1

 Haemoglobin g/l

75.0–138.9

95.0 (78.0–112.0); 3

95.9 (79.3–124.0); 3

(72.5–93.8); 2

81.5 (64.0–121.0); 6

87.3 (69.9–116.7); 6

83.2 (60.7–116.3); 5

72.5 (49.0–106.0); 4

78.8 (65.1–97.9); 3

96.8; 1

 Erythrocytes × 1012/l

3.47–6.65

4.02 (3.41–5.10); 3

3.98 (2.69–4.43); 3

(4.29–4.98); 2

3.64 (2.70–5.21); 6

3.79 (3.17–4.55); 6

4.67 (2.61–5.91); 5

3.17 (2.14–4.24); 4

4.86 (3.53–5.92); 3

5.32; 1

 Plateles × 109/l

282–946

62 (21–107); 3

638 (543–910); 3

(571–849); 2

80 (10–229); 6

549 (358–972); 6

925 (580–1180); 5

202 (31–266); 4

723 (215–998); 3

971; 1

 Normoblasts × 1012/l

 

0.09 (0.08–0.13); 3

0.08 (0.06–0.11); 3

(0.00–0.04); 2

0.06 (0.03–0.22); 6

0.05 (0.00–0.15); 6

0.22 (0.00–0.59); 5

0.09 (0.02–0.35); 4

0.33 (0.17–0.38); 3

0.93; 1

Blood chemistry

 Creatinin µmol/l

38–142

95 (84–99); 3

63 (57–67); 3

(51–55); 2

86.5 (55–100); 6

57 (53–73); 6

68 (55–78); 5

103 (86–106); 3

63 (52–72); 4

87; 1

 GLDH U/l

0–11.5

1.0 (0.5–2.0); 3

(0.6–1.4); 2

n.a.

1.3 (0.6–2.1); 5

0.9 (0.1–2.1); 6

0.6 (0.5–2.0); 3

0.7 (0.3–0.9); 3

0.6 (0.2–1.0); 4

0.5; 1

 LDH U/l

409–1549

2013 (1986–2830); 3

1105 (901–1445); 3

(830–1061); 2

1893 (1150–2072); 6

1309 (909–1767); 6

806 (711–1255); 5

1301 (1185–1388); 3

710 (538–804); 4

824; 1

 CK U/l

43–3343

598 (509–850); 3

98 (93–144); 3

(85–195); 2

461 (292–1515); 6

194 (66–296); 6

91 (67–288); 5

303 (241–331); 3

87 (37–111); 4

96; 1

 ASAT U/l

13.7–122.8

36 (36–55); 3

11 (11–22); 3

(12–20); 2

25 (20–36); 5

20 (9–29); 6

14 (11–15); 5

19 (17–26); 3

9 (7–14); 4

11; 1

 Plasma protein g/l

36.65–71.71

19.9 (19.5–22.9); 3

24.8 (23.9–27.8); 3

(27.0–28.5); 2

23.9 (20.9–29.5); 5

28.8 (23.3–31.5); 6

31.2 (27.2–33.1); 5

22.7 (21.9–27.4); 3

30.1 (27.5–30.7); 4

31.4; 1

 Sodium mmol/l

136.0–151.0

130.9 (129.0–132.5); 3

132.6 (130.6–133.4); 3

(129.6–134.5); 2

130.8 (125.8–138.7); 6

133.7 (133.0–137.1); 6

131.7 (130.1–135.2); 5

132.0 (129.9–134.4); 3

132.3 (129.1–135.8); 4

129.5; 1

 Potassium mmol/l

3.78–6.92

4.46 (3.32–4.75); 3

6.59 (5.74–7.60); 3

(5.23–7.04); 2

4.66 (3.99–6.22); 6

5.75 (4.96–6.89); 6

5.79 (5.15–6.12); 5

4.65 (4.44–5.50); 3

5.26 (4.85–5.80); 4

4.97; 1

Acute phase proteins

 Haptoglobin mg/ml

 

(0.03–0.05); 2

0.02 (0.02–0.54); 3

(0.01–0.02); 2

0.04 (0.04–0.06); 3

0.39 (0.04–0.91); 6

0.27 (0.02–1.13); 5

(0.02–0.02); 2

2.62 (2.20–3.00); 4

1.27; 1

 CRP mg/l

 

(<0.05–0.8); 3

3.0 (0.7–13.3); 3

(1.2–3.4); 2

0.7 (<0.05–7.3); 5

7.5 (1.3–203.2); 6

11.0 (<0.05–40.9); 5

(<0.05–1.7); 3

30.0 (9.5–220.1); 4

0.7; 1

 LBP mg/l

 

2.00 (1.00–6.50); 3

2.10 (1.20–4.00); 3

(2.1–4.9); 2

2.80 (0.80–5.10); 5

4.25 (1.70–9.60); 6

4.7 (1.1–8.8); 5

1.20 (1.20–1.30); 3

5.05 (1.20–9.00); 4

7;1

  1. GLDH glutamate dehydrogenase, LDH lactate dehydrogenase, CK creatine kinase, ASAT aspartate transaminase, CRP C-reactive protein, LBP lipopolysaccharide binding protein, n.a. not assessed. T1 timerange 1, preinfectionem, T2 timerange 2, day 4-day 6 p.i., T3 timerange, day 7-day 12 p.i.